Sera Prognostics Stock (NASDAQ: SERA) stock price, news, charts, stock research, profile.
You can purchase shares of Sera Prognostics (NASDAQ:SERA) through any online brokerage.
Other companies in Sera Prognostics’s space includes: Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
Sera Prognostics has a consensus price target of $8.92.
The stock price for Sera Prognostics (NASDAQ: SERA) is $8.78 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics’s Q4 earnings are confirmed for Wednesday, March 19, 2025.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.